Business Standard

Sunday, January 19, 2025 | 01:30 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Cancer-fighting potential in nearly 50 drugs for other conditions: Study

"We found that a surprising number of non-oncology drugs are able to kill cancer cell lines in the lab," said Steven Corsello of Dana-Farber Cancer Institute

Domestic drugmakers
Premium

Representative Image

Julie Steenhuysen | Reuters
US researchers who tested the cancer-fighting properties of more than 4,500 non-cancer drugs found nearly 50 drugs for other conditions showed at least some cancer-killing ability.
 
“We found that a surprising number of non-oncology drugs are able to kill cancer cell lines in the lab,” said Steven Corsello of Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard University, who led the research.
 
Bruce Bloom of Cambridge, Massachusetts-based Healx, a company that uses artificial intelligence to discover drugs for rare diseases, told Reuters Health by email the new drug targets and mechanisms of action identified by the researchers

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in